Accuray (ARAY) Long-Term Investments (2019 - 2026)
Accuray's (ARAY) quarterly Long-Term Investments came in at $6.3 million in Q1 2026, down 31.92% year-on-year from $9.3 million in Q1 2025, and up 8.91% quarter-over-quarter from $5.8 million in Q4 2025.
Accuray (ARAY) Long-Term Investments (2019 - 2026) Analysis & Trends
Accuray's Long-Term Investments history runs 8 years deep, the most recent figure standing at $6.3 million for Q1 2026.
- On a quarterly basis, Long-Term Investments fell 31.92% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 31.92% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, down 53.06% from the prior year.
- Long-Term Investments climbed to $6.3 million in Q1 2026 per ARAY's latest filing, from $5.8 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $15.1 million in Q2 2023 and bottomed at $4.0 million in Q3 2025.
- The 5-year median for Long-Term Investments is $12.3 million (2022), against an average of $10.6 million.
- Across the five-year window, Long-Term Investments gained 18.41% in 2023 and tumbled 54.79% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $12.3 million in 2022, then climbed by 18.41% to $14.5 million in 2023, then decreased by 11.69% to $12.8 million in 2024, then tumbled by 54.79% to $5.8 million in 2025, then gained by 8.91% to $6.3 million in 2026.
- Per Business Quant, the three latest ARAY Long-Term Investments figures stand at $6.3 million (Q1 2026), $5.8 million (Q4 2025), and $4.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 6.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.32 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 4.01 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | 9.28 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | 6.05 Mn |
| Jun 30, 2024 | 9.83 Mn |
| Mar 31, 2024 | 13.59 Mn |
| Dec 31, 2023 | 14.54 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Jun 30, 2023 | 15.13 Mn |
| Mar 31, 2023 | 12.22 Mn |
| Dec 31, 2022 | 12.28 Mn |
| Sep 30, 2022 | 12.78 Mn |
| Jun 30, 2022 | 13.88 Mn |
| Mar 31, 2022 | 14.25 Mn |
| Dec 31, 2021 | 14.68 Mn |
| Sep 30, 2021 | 14.74 Mn |
| Jun 30, 2021 | 15.94 Mn |